Compare CCS & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCS | INVA |
|---|---|---|
| Founded | 2000 | 1996 |
| Country | United States | United States |
| Employees | 1873 | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.5B |
| IPO Year | 2014 | 2004 |
| Metric | CCS | INVA |
|---|---|---|
| Price | $69.28 | $19.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $74.80 | $36.80 |
| AVG Volume (30 Days) | 258.2K | ★ 638.5K |
| Earning Date | 01-28-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | N/A | ★ 53.96 |
| EPS | ★ 6.93 | 1.52 |
| Revenue | ★ $4,157,669,000.00 | $388,521,000.00 |
| Revenue This Year | N/A | $13.23 |
| Revenue Next Year | $8.74 | $8.58 |
| P/E Ratio | ★ $9.97 | $12.85 |
| Revenue Growth | N/A | ★ 10.14 |
| 52 Week Low | $50.42 | $16.52 |
| 52 Week High | $81.10 | $22.76 |
| Indicator | CCS | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 64.98 | 52.55 |
| Support Level | $65.40 | $19.29 |
| Resistance Level | $70.09 | $19.80 |
| Average True Range (ATR) | 2.72 | 0.50 |
| MACD | 0.71 | 0.04 |
| Stochastic Oscillator | 93.99 | 78.05 |
Century Communities Inc is engaged in the development, design, construction, marketing, and selling of single-family attached and detached homes. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its sales representatives and independent real estate brokers. The company generates the majority of its revenue from the Mountain segment.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.